Fast Moving Stocks: Asterias Biotherapeutics, Inc. (NYSEMKT:AST), Marvell Technology Group Ltd. (NASDAQ:MRVL), CEL-SCI Corporation (NYSEMKT:CVM), Schlumberger Limited (NYSE:SLB), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) belongs to Healthcare sector. Its weekly performance is 19.80%. On last trading day company shares ended up $4.90. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) distance from 50-day simple moving average (SMA50) is -42.10%. On 30 June, Asterias Biotherapeutics, Inc. (NYSEMKT:AST) announced that it has been added to the Russell 2000®, Russell 3000®, Russell Global and Russell Microcap® indexes following Russell Investments’ (“Russell”) reconstitution of its comprehensive set of U.S. and global equity indexes after the close of the U.S. markets.

Marvell Technology Group Ltd. (NASDAQ:MRVL) shares fell -2.05% in last trading session and ended the day at $12.92. MRVL Gross Margin is 51.00% and its return on assets is 6.00%. Marvell Technology Group Ltd. (NASDAQ:MRVL) quarterly performance is -14.35%. Marvell Technology Group Ltd. (NASDAQ:MRVL)‘s stock had its “buy” rating reiterated by stock analysts at Cowen and Company in a report issued on Tuesday.

CEL-SCI Corporation (NYSEMKT:CVM) belongs to Healthcare sector. Its weekly performance is 12.66%. On last trading day company shares ended up $0.70. CEL-SCI Corporation (NYSEMKT:CVM) distance from 50-day simple moving average (SMA50) is -8.53%. On 1 July, CEL-SCI Corporation (NYSEMKT:CVM) announced that in June it has enrolled 25 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in just diagnosed, not yet treated patients with head and neck cancer. Total patient enrollment is now 488 as of June 30, 2015 in the world’s largest Phase 3 study in head and neck cancer.

Schlumberger Limited (NYSE:SLB) shares advanced 1.19% in last trading session and ended the day at $85.29. SLB Gross Margin is 23.00% and its return on assets is 7.20%. Schlumberger Limited (NYSE:SLB) quarterly performance is -3.42%. On 10 July, Schlumberger Limited (NYSE:SLB) announced that it has become the first service/supply contractor to voluntarily achieve SEMS certification to Center for Offshore Safety Program expectations.

On 14 July, Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares advanced 10.59% and was closed at $14.83. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) year to date (YTD) performance is -9.96%. On 1 July, Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) announced that on June 30, 2015, the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 115,500 shares of common stock to four new employees, with all four grants having a grant date of June 30, 2015 (the “Q2 2015 Inducement Grants”).

Leave a Reply

Your email address will not be published. Required fields are marked *